|
G |
A2m |
alpha-2-macroglobulin |
increases expression |
EXP |
Isoniazid results in increased expression of A2M mRNA |
CTD |
PMID:12883083 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
multiple interactions decreases expression |
EXP ISO |
[Lipopolysaccharides co-treated with Isoniazid] results in decreased expression of ABCB11 mRNA; obeticholic acid inhibits the reaction [Isoniazid results in decreased expression of ABCB11 mRNA] [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] affects the expression of ABCB11 protein [Rifampin co-treated with Isoniazid] results in decreased expression of ABCB11 protein Isoniazid results in decreased expression of ABCB11 protein |
CTD |
PMID:25331106 PMID:25886055 PMID:32673658 PMID:35835356 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
increases expression |
EXP |
Isoniazid results in increased expression of ABCC1 mRNA |
CTD |
PMID:11752103 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions decreases expression |
EXP |
[Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] affects the expression of ABCC2 protein; [Lipopolysaccharides co-treated with Isoniazid] results in decreased expression of ABCC2 mRNA Isoniazid results in decreased expression of ABCC2 mRNA |
CTD |
PMID:25331106 PMID:32673658 PMID:35835356 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
multiple interactions decreases expression |
EXP |
[Lipopolysaccharides co-treated with Isoniazid] results in increased expression of ABCC3 mRNA; obeticholic acid inhibits the reaction [Isoniazid results in decreased expression of ABCC3 mRNA] |
CTD |
PMID:25331106 PMID:32673658 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
decreases expression |
EXP |
Isoniazid results in decreased expression of ABCC4 mRNA |
CTD |
PMID:32673658 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Abcc6 |
ATP binding cassette subfamily C member 6 |
decreases expression |
EXP |
Isoniazid results in decreased expression of ABCC6 mRNA |
CTD |
PMID:16260000 |
|
NCBI chr 1:96,447,224...96,501,464
Ensembl chr 1:96,447,251...96,501,464
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
decreases expression |
ISO |
Isoniazid results in decreased expression of ACE2 mRNA |
CTD |
PMID:32808185 |
|
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
multiple interactions |
EXP |
[Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in increased expression of ACSL4 protein |
CTD |
PMID:36878459 |
|
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
|
|
G |
Afp |
alpha-fetoprotein |
decreases expression |
ISO |
Isoniazid results in decreased expression of AFP mRNA |
CTD |
PMID:30008028 |
|
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Agpat3 |
1-acylglycerol-3-phosphate O-acyltransferase 3 |
increases expression multiple interactions |
EXP |
Isoniazid results in increased expression of AGPAT3 mRNA [Zidovudine co-treated with Isoniazid] results in increased expression of AGPAT3 mRNA; silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in increased expression of AGPAT3 mRNA] |
CTD |
PMID:28619387 |
|
NCBI chr20:10,330,960...10,415,358
Ensembl chr20:10,384,507...10,415,358
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
increases expression |
ISO |
Isoniazid results in increased expression of AKR1B10 mRNA |
CTD |
PMID:28444390 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Alas1 |
5'-aminolevulinate synthase 1 |
increases expression |
ISO |
Isoniazid results in increased expression of ALAS1 protein |
CTD |
PMID:27438535 PMID:30517741 |
|
NCBI chr 8:106,876,514...106,889,917
Ensembl chr 8:106,876,514...106,889,917
|
|
G |
Alb |
albumin |
affects binding |
ISO |
Isoniazid binds to ALB protein |
CTD |
PMID:25489718 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
increases activity multiple interactions |
ISO |
Isoniazid results in increased activity of ALPL protein [Rifampin co-treated with Isoniazid] results in increased activity of ALPL protein |
CTD |
PMID:25886055 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Apoa4 |
apolipoprotein A4 |
affects response to substance |
ISO |
APOA4 affects the susceptibility to Isoniazid |
CTD |
PMID:24848797 |
|
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
|
|
G |
Apoa5 |
apolipoprotein A5 |
multiple interactions decreases expression |
EXP |
[Zidovudine co-treated with Isoniazid] results in decreased expression of APOA5 mRNA; silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in decreased expression of APOA5 mRNA] Isoniazid results in decreased expression of APOA5 mRNA |
CTD |
PMID:28619387 |
|
NCBI chr 8:46,561,180...46,563,818
Ensembl chr 8:46,561,229...46,563,816
|
|
G |
App |
amyloid beta precursor protein |
increases expression |
ISO |
Isoniazid results in increased expression of APP mRNA |
CTD |
PMID:30008028 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Asl |
argininosuccinate lyase |
increases activity multiple interactions |
EXP |
Isoniazid results in increased activity of ASL protein [Isoniazid co-treated with Zidovudine] results in increased activity of ASL protein; Silybin inhibits the reaction [[Isoniazid co-treated with Zidovudine] results in increased activity of ASL protein] |
CTD |
PMID:28619387 |
|
NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662
|
|
G |
Atp1b1 |
ATPase Na+/K+ transporting subunit beta 1 |
increases expression |
ISO |
Isoniazid results in increased expression of ATP1B1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
|
|
G |
Atp5f1b |
ATP synthase F1 subunit beta |
affects expression |
ISO |
Isoniazid affects the expression of ATP5F1B mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 7:515,454...521,858
Ensembl chr 7:515,460...567,273
|
|
G |
Atp5mc1 |
ATP synthase membrane subunit c locus 1 |
affects expression |
ISO |
Isoniazid affects the expression of ATP5MC1 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr10:81,024,056...81,026,780
Ensembl chr10:81,023,925...81,027,124 Ensembl chr10:81,023,925...81,027,124
|
|
G |
Atp5mc3 |
ATP synthase membrane subunit c locus 3 |
affects expression |
ISO |
Isoniazid affects the expression of ATP5MC3 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 3:58,810,535...58,813,185
Ensembl chr 3:58,810,535...58,814,279
|
|
G |
Atp5pb |
ATP synthase peripheral stalk-membrane subunit b |
affects expression |
ISO |
Isoniazid affects the expression of ATP5PB mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 2:193,424,138...193,435,418
Ensembl chr 2:193,424,047...193,435,418
|
|
G |
Atp5pf |
ATP synthase peripheral stalk subunit F6 |
affects expression |
ISO |
Isoniazid affects the expression of ATP5PF mRNA |
CTD |
PMID:24848797 |
|
NCBI chr11:23,881,594...23,889,581
Ensembl chr11:23,881,592...23,889,119
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression affects expression |
ISO EXP |
[Isoniazid co-treated with Rifampin] results in increased expression of BAX protein; Ursodeoxycholic Acid inhibits the reaction [[Isoniazid co-treated with Rifampin] results in increased expression of BAX protein] Isoniazid results in increased expression of BAX protein Quercetin inhibits the reaction [Isoniazid results in increased expression of BAX protein] chrysin inhibits the reaction [Isoniazid results in increased expression of BAX protein] Isoniazid results in increased expression of BAX mRNA Isoniazid affects the expression of BAX protein |
CTD |
PMID:20433247 PMID:21419764 PMID:31332904 PMID:33121995 PMID:33771660 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbox1 |
gamma-butyrobetaine hydroxylase 1 |
increases expression |
ISO |
Isoniazid results in increased expression of BBOX1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 3:96,822,654...96,871,786
Ensembl chr 3:96,822,655...96,871,458
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
ISO |
[Isoniazid co-treated with Rifampin] results in decreased expression of BCL2 protein; Ursodeoxycholic Acid inhibits the reaction [[Isoniazid co-treated with Rifampin] results in decreased expression of BCL2 protein] Quercetin inhibits the reaction [Isoniazid results in decreased expression of BCL2 protein] Isoniazid results in decreased expression of BCL2 mRNA |
CTD |
PMID:20433247 PMID:21419764 PMID:31332904 PMID:33771660 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases cleavage increases expression increases activity |
ISO EXP |
[Isoniazid co-treated with Rifampin] results in increased activity of CASP3 protein; HGF protein inhibits the reaction [[Isoniazid co-treated with Rifampin] results in increased activity of CASP3 protein]; Ursodeoxycholic Acid inhibits the reaction [[Isoniazid co-treated with Rifampin] results in increased activity of CASP3 protein] acadesine promotes the reaction [Isoniazid results in increased cleavage of CASP3 protein]; Quercetin inhibits the reaction [Isoniazid results in increased cleavage of CASP3 protein] Isoniazid results in increased expression of CASP3 mRNA [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in increased expression of CASP3 Isoniazid results in increased activity of CASP3 protein |
CTD |
PMID:20433247 PMID:21419764 PMID:23764483 PMID:28556920 PMID:31332904 PMID:33771660 PMID:35835356 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
increases cleavage multiple interactions increases activity |
ISO |
Isoniazid results in increased cleavage of CASP9 protein Quercetin inhibits the reaction [Isoniazid results in increased cleavage of CASP9 protein] Isoniazid results in increased activity of CASP9 protein |
CTD |
PMID:20433247 PMID:31332904 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Casr |
calcium-sensing receptor |
affects expression |
EXP |
Isoniazid affects the expression of CASR mRNA |
CTD |
PMID:20623750 |
|
NCBI chr11:64,235,251...64,304,811
Ensembl chr11:64,235,251...64,304,811
|
|
G |
Cat |
catalase |
decreases activity multiple interactions |
EXP ISO |
Isoniazid results in decreased activity of CAT protein [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of CAT protein; chrysin inhibits the reaction [Isoniazid results in decreased activity of CAT protein] |
CTD |
PMID:20433247 PMID:33121995 PMID:33771660 PMID:36878459 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
decreases expression |
EXP |
Isoniazid results in decreased expression of CCR2 mRNA |
CTD |
PMID:20623750 |
|
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
decreases expression |
ISO |
Isoniazid results in decreased expression of CEBPA mRNA; Isoniazid results in decreased expression of CEBPA protein |
CTD |
PMID:24128855 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
decreases expression |
ISO |
Isoniazid results in decreased expression of CEBPB protein |
CTD |
PMID:24128855 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cebpd |
CCAAT/enhancer binding protein delta |
decreases expression |
ISO |
Isoniazid results in decreased expression of CEBPD mRNA; Isoniazid results in decreased expression of CEBPD protein |
CTD |
PMID:24128855 |
|
NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829
|
|
G |
Chpt1 |
choline phosphotransferase 1 |
affects response to substance |
ISO |
CHPT1 affects the susceptibility to Isoniazid |
CTD |
PMID:24848797 |
|
NCBI chr 7:22,866,455...22,915,111
Ensembl chr 7:22,863,027...22,915,103
|
|
G |
Cldn2 |
claudin 2 |
increases expression |
ISO |
Isoniazid results in increased expression of CLDN2 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr X:103,459,870...103,473,794
Ensembl chr X:103,459,780...103,474,838
|
|
G |
Cox11 |
cytochrome c oxidase copper chaperone COX11 |
affects expression |
ISO |
Isoniazid affects the expression of COX11 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr10:75,458,735...75,465,322
Ensembl chr10:75,458,749...75,465,322
|
|
G |
Cox17 |
cytochrome c oxidase copper chaperone COX17 |
affects expression |
ISO |
Isoniazid affects the expression of COX17 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr11:62,400,733...62,406,507
|
|
G |
Cox5b |
cytochrome c oxidase subunit 5B |
affects expression |
ISO |
Isoniazid affects the expression of COX5B mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 9:38,921,980...38,923,806
Ensembl chr 9:38,921,967...38,925,052
|
|
G |
Cox6a1 |
cytochrome c oxidase subunit 6A1 |
affects expression |
ISO |
Isoniazid affects the expression of COX6A1 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr12:41,261,983...41,265,037
Ensembl chr12:41,261,967...41,265,041
|
|
G |
Cox6b1 |
cytochrome c oxidase subunit 6B1 |
affects expression |
ISO |
Isoniazid affects the expression of COX6B1 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 1:85,875,080...85,884,081
Ensembl chr 1:85,875,109...85,884,001 Ensembl chr 2:85,875,109...85,884,001 Ensembl chr 5:85,875,109...85,884,001
|
|
G |
Cox7a2 |
cytochrome c oxidase subunit 7A2 |
affects expression |
ISO |
Isoniazid affects the expression of COX7A2 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 8:80,716,824...80,720,922
Ensembl chr14:51,301,168...51,301,633 Ensembl chr 8:51,301,168...51,301,633
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
affects expression |
ISO |
Isoniazid affects the expression of CPT1A mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
increases secretion |
ISO |
Isoniazid results in increased secretion of CXCL10 protein |
CTD |
PMID:28444390 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cyb5a |
cytochrome b5 type A |
multiple interactions decreases expression |
EXP |
[Zidovudine co-treated with Isoniazid] results in decreased expression of CYB5A mRNA; silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in decreased expression of CYB5A mRNA] Isoniazid results in decreased expression of CYB5A mRNA |
CTD |
PMID:28619387 |
|
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[Isoniazid co-treated with Rifampin] results in decreased expression of CYP1A2 mRNA; [Isoniazid co-treated with Rifampin] results in decreased expression of CYP1A2 protein; dendrobine inhibits the reaction [[Isoniazid co-treated with Rifampin] results in decreased expression of CYP1A2 mRNA]; dendrobine inhibits the reaction [[Isoniazid co-treated with Rifampin] results in decreased expression of CYP1A2 protein] |
CTD |
PMID:32633153 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
increases expression |
EXP |
Isoniazid results in increased expression of CYP27A1 mRNA |
CTD |
PMID:32673658 |
|
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
|
|
G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
decreases activity multiple interactions |
ISO |
Isoniazid results in decreased activity of CYP2C8 protein torsemide inhibits the reaction [Isoniazid results in decreased activity of CYP2C8 protein] |
CTD |
PMID:15304522 |
|
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
affects response to substance increases metabolic processing multiple interactions increases expression increases activity increases response to substance decreases activity |
ISO EXP |
CYP2E1 gene polymorphism affects the susceptibility to Isoniazid; CYP2E1 gene SNP affects the susceptibility to Isoniazid CYP2E1 protein results in increased metabolism of Isoniazid 2-(allylthio)pyrazine inhibits the reaction [Isoniazid results in increased expression of CYP2E1 protein]; [Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased activity of CYP2E1 protein; [Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of CYP2E1 mRNA; [Isoniazid results in increased activity of CYP2E1 protein] which results in increased metabolism of 4-dichlorobenzene; [Isoniazid results in increased expression of CYP2E1] which results in increased metabolism of Acetaminophen; [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased activity of CYP2E1 protein]; [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of CYP2E1 mRNA]; diphenyleneiodonium inhibits the reaction [Isoniazid results in increased activity of CYP2E1 protein]; Isoniazid inhibits the reaction [CYP2E1 protein results in increased reduction of Tirapazamine]; Isoniazid results in increased expression of and results in increased activity of CYP2E1 protein; Methionine inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased activity of CYP2E1 protein]; Methionine inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of CYP2E1 mRNA]; NADP promotes the reaction [Isoniazid results in decreased activity of CYP2E1 protein]; Rifampin inhibits the reaction [Isoniazid results in increased expression of CYP2E1 protein]; Thiram inhibits the reaction [Isoniazid results in increased activity of CYP2E1 protein]; Tiopronin inhibits the reaction [Isoniazid results in increased activity of CYP2E1 protein] Isoniazid results in increased expression of CYP2E1; Isoniazid results in increased expression of CYP2E1 mRNA; Isoniazid results in increased expression of CYP2E1 protein [Isoniazid co-treated with Rifampin co-treated with dendrobine] results in decreased expression of CYP2E1 mRNA; [Isoniazid co-treated with Rifampin] results in decreased expression of CYP2E1 mRNA; Berberine inhibits the reaction [Isoniazid results in increased expression of CYP2E1 mRNA]; NADP promotes the reaction [Isoniazid results in decreased activity of CYP2E1 protein] GSTM1 protein inhibits the reaction [CYP2E1 protein results in increased susceptibility to Isoniazid]; NADP promotes the reaction [Isoniazid results in decreased activity of CYP2E1 protein] |
CTD |
PMID:3113478 PMID:7710944 PMID:8074729 PMID:9051121 PMID:9065729 PMID:9129171 PMID:11752103 PMID:12458634 PMID:12668988 PMID:15132840 PMID:15205388 PMID:15763544 PMID:17950035 PMID:18754103 PMID:19683030 PMID:20485159 PMID:20566340 PMID:22342832 PMID:23211455 PMID:24929095 PMID:25683034 PMID:26880746 PMID:27919644 PMID:28762043 PMID:32633153 PMID:39047805 More...
|
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions increases response to substance decreases activity |
EXP ISO |
[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of CYP3A2 mRNA; [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of CYP3A2 mRNA]; [SOD2 co-treated with CYP3A4] affects the susceptibility to Isoniazid; Methionine inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of CYP3A2 mRNA] CYP3A4 protein results in increased susceptibility to Isoniazid Isoniazid results in decreased activity of CYP3A4 protein |
CTD |
PMID:15005856 PMID:15304522 PMID:19501153 PMID:21540358 PMID:27919644 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
increases expression multiple interactions increases activity |
EXP |
Isoniazid results in increased expression of CYP3A23-3A1 mRNA diphenyleneiodonium inhibits the reaction [Isoniazid results in increased activity of CYP3A23-3A1 protein] |
CTD |
PMID:12883083 PMID:26880746 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
multiple interactions increases expression |
EXP ISO |
[Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of CYP7A1 protein; [Lipopolysaccharides co-treated with Isoniazid] results in increased expression of CYP7A1 mRNA; obeticholic acid inhibits the reaction [Isoniazid results in increased expression of CYP7A1 mRNA] [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in increased expression of CYP7A1 protein; [Isoniazid co-treated with Vitamin B 6] results in increased expression of CYP7A1 mRNA |
CTD |
PMID:25331106 PMID:32673658 PMID:35835356 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression decreases expression |
EXP ISO |
Isoniazid results in increased expression of DDIT3 mRNA Isoniazid results in decreased expression of DDIT3 mRNA |
CTD |
PMID:12883083 PMID:30008028 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Depp1 |
DEPP autophagy regulator 1 |
increases expression |
ISO |
Isoniazid results in increased expression of DEPP1 mRNA |
CTD |
PMID:17175557 |
|
NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542
|
|
G |
Epx |
eosinophil peroxidase |
increases oxidation multiple interactions |
ISO |
EPX protein results in increased oxidation of Isoniazid [EPX protein results in increased oxidation of Isoniazid] which results in increased chemical synthesis of isonicotinyl-NAD |
CTD |
PMID:30922765 |
|
NCBI chr10:72,666,865...72,677,952
Ensembl chr10:72,666,865...72,677,952
|
|
G |
Fech |
ferrochelatase |
decreases expression |
ISO |
Isoniazid results in decreased expression of FECH protein |
CTD |
PMID:27438535 PMID:30517741 |
|
NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
decreases activity |
ISO |
Isoniazid results in decreased activity of G6PD protein |
CTD |
PMID:20433247 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
decreases expression |
EXP |
Isoniazid results in decreased expression of GADD45A mRNA |
CTD |
PMID:20623750 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
increases expression |
EXP |
Isoniazid results in increased expression of GAPDH mRNA |
CTD |
PMID:12883083 |
|
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions decreases expression increases expression |
ISO EXP |
Isoniazid inhibits the reaction [2-tert-butylhydroquinone results in increased expression of GCLC mRNA] Isoniazid results in decreased expression of GCLC mRNA Isoniazid results in increased expression of GCLC mRNA chrysin inhibits the reaction [Isoniazid results in increased expression of GCLC mRNA] |
CTD |
PMID:24128855 PMID:33121995 PMID:33771660 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
decreases expression multiple interactions increases expression |
ISO EXP |
Isoniazid results in decreased expression of GCLM mRNA chrysin inhibits the reaction [Isoniazid results in increased expression of GCLM mRNA] |
CTD |
PMID:30008028 PMID:33121995 PMID:33771660 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions increases expression |
EXP |
chrysin inhibits the reaction [Isoniazid results in increased expression of GFAP mRNA]; chrysin inhibits the reaction [Isoniazid results in increased expression of GFAP protein] Isoniazid results in increased expression of GFAP mRNA; Isoniazid results in increased expression of GFAP protein |
CTD |
PMID:33121995 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
multiple interactions |
EXP |
[Lipopolysaccharides co-treated with Isoniazid] results in increased activity of GGT1 protein |
CTD |
PMID:25331106 |
|
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
multiple interactions increases activity |
ISO |
[Rifampin co-treated with Isoniazid] results in increased activity of GOT1 protein Isoniazid results in increased activity of GOT1 protein |
CTD |
PMID:25886055 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases activity multiple interactions increases expression |
EXP ISO |
Isoniazid results in increased activity of GPT protein [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of GPT protein; [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in increased expression of GPT protein; [Lipopolysaccharides co-treated with Isoniazid] results in increased activity of GPT protein; HIF1A protein affects the reaction [[Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in increased expression of GPT protein]; Isoniazid promotes the reaction [Zidovudine results in increased activity of GPT protein]; Silybin inhibits the reaction [Isoniazid promotes the reaction [Zidovudine results in increased activity of GPT protein]] Isoniazid results in increased expression of GPT protein Quercetin inhibits the reaction [Isoniazid results in increased expression of GPT protein] [Isoniazid co-treated with Rifampin] results in increased expression of GPT protein; [Rifampin co-treated with Isoniazid] results in increased activity of GPT protein; dendrobine inhibits the reaction [[Isoniazid co-treated with Rifampin] results in increased expression of GPT protein] |
CTD |
PMID:25331106 PMID:25886055 PMID:28619387 PMID:31332904 PMID:32633153 PMID:35835356 PMID:36878459 More...
|
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
multiple interactions |
EXP |
[Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of GPX4 mRNA; [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of GPX4 protein; HIF1A protein affects the reaction [[Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of GPX4 protein] |
CTD |
PMID:36878459 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
increases expression |
EXP |
Isoniazid results in increased expression of GSTA2 mRNA |
CTD |
PMID:12883083 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
multiple interactions decreases response to substance |
ISO |
GSTM1 protein inhibits the reaction [CYP2E1 protein results in increased susceptibility to Isoniazid] GSTM1 protein results in decreased susceptibility to Isoniazid |
CTD |
PMID:28762043 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
decreases expression |
EXP |
Isoniazid results in decreased expression of GSTP1 mRNA |
CTD |
PMID:20623750 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
multiple interactions |
ISO |
GSTT1 gene polymorphism affects the susceptibility to [Isoniazid co-treated with Rifampin]; GSTT1 gene polymorphism results in increased susceptibility to [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide] |
CTD |
PMID:18397238 PMID:20485159 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
affects expression |
EXP |
Isoniazid affects the expression of HAVCR1 mRNA |
CTD |
PMID:20623750 |
|
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Hgf |
hepatocyte growth factor |
multiple interactions |
ISO |
HGF protein inhibits the reaction [[Isoniazid co-treated with Rifampin] results in increased abundance of Reactive Oxygen Species]; HGF protein inhibits the reaction [[Isoniazid co-treated with Rifampin] results in increased activity of CASP3 protein] |
CTD |
PMID:23764483 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
EXP |
[Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of HIF1A mRNA; [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of HIF1A protein; HIF1A protein affects the reaction [[Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of GPX4 protein]; HIF1A protein affects the reaction [[Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of SLC7A11 protein]; HIF1A protein affects the reaction [[Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in increased expression of GPT protein] |
CTD |
PMID:36878459 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions decreases expression increases expression |
ISO EXP |
Isoniazid inhibits the reaction [2-tert-butylhydroquinone results in increased expression of HMOX1 mRNA] Isoniazid results in decreased expression of HMOX1 mRNA Isoniazid results in increased expression of HMOX1 mRNA chrysin inhibits the reaction [Isoniazid results in increased expression of HMOX1 mRNA] |
CTD |
PMID:24128855 PMID:33121995 PMID:33771660 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hmox2 |
heme oxygenase 2 |
increases expression |
EXP |
Isoniazid results in increased expression of HMOX2 mRNA |
CTD |
PMID:12883083 |
|
NCBI chr10:10,797,076...10,831,178
Ensembl chr10:10,797,055...10,831,148
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
increases expression |
EXP |
Isoniazid results in increased expression of HPRT1 mRNA |
CTD |
PMID:12883083 |
|
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
|
|
G |
Ifng |
interferon gamma |
increases secretion |
ISO |
Isoniazid results in increased secretion of IFNG protein |
CTD |
PMID:28444390 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il10 |
interleukin 10 |
increases secretion |
ISO |
Isoniazid results in increased secretion of IL10 protein |
CTD |
PMID:28444390 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12a |
interleukin 12A |
increases secretion |
ISO |
Isoniazid results in increased secretion of IL12A protein |
CTD |
PMID:28444390 |
|
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
|
|
G |
Il12b |
interleukin 12B |
increases secretion |
ISO |
Isoniazid results in increased secretion of IL12B protein |
CTD |
PMID:28444390 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il17a |
interleukin 17A |
increases secretion |
ISO |
Isoniazid results in increased secretion of IL17A protein |
CTD |
PMID:28444390 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il1a |
interleukin 1 alpha |
increases secretion increases expression |
ISO |
Isoniazid results in increased secretion of IL1A protein Isoniazid results in increased expression of IL1A mRNA |
CTD |
PMID:28444390 PMID:32816093 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
increases secretion increases expression multiple interactions |
ISO EXP |
Isoniazid results in increased secretion of IL1B protein Isoniazid results in increased expression of IL1B mRNA chrysin inhibits the reaction [Isoniazid results in increased expression of IL1B mRNA] |
CTD |
PMID:28444390 PMID:32816093 PMID:33121995 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
[Isoniazid co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA |
CTD |
PMID:29594315 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il24 |
interleukin 24 |
increases expression |
ISO |
Isoniazid results in increased expression of IL24 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
|
|
G |
Il6 |
interleukin 6 |
increases expression increases secretion multiple interactions |
ISO EXP |
Isoniazid results in increased expression of IL6 protein Isoniazid results in increased secretion of IL6 protein chrysin inhibits the reaction [Isoniazid results in increased expression of IL6 mRNA] |
CTD |
PMID:19575532 PMID:28444390 PMID:33121995 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Inhbe |
inhibin subunit beta E |
increases expression |
ISO |
Isoniazid results in increased expression of INHBE mRNA |
CTD |
PMID:17175557 |
|
NCBI chr 7:63,176,221...63,179,209
Ensembl chr 7:63,176,219...63,179,172
|
|
G |
Izumo1r |
IZUMO1 receptor, JUNO |
decreases expression |
ISO |
Isoniazid results in decreased expression of IZUMO1R protein |
CTD |
PMID:33771660 |
|
NCBI chr 8:11,744,384...11,748,131
Ensembl chr 8:11,725,863...11,748,465
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
decreases expression |
ISO |
Isoniazid results in decreased expression of KEAP1 mRNA |
CTD |
PMID:33771660 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Lamp1 |
lysosomal-associated membrane protein 1 |
affects response to substance |
ISO |
LAMP1 affects the susceptibility to Isoniazid |
CTD |
PMID:24848797 |
|
NCBI chr16:76,355,982...76,380,700
Ensembl chr16:76,355,984...76,381,883
|
|
G |
Lcn2 |
lipocalin 2 |
increases expression |
EXP |
Isoniazid results in increased expression of LCN2 mRNA |
CTD |
PMID:20623750 |
|
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Map2 |
microtubule-associated protein 2 |
affects expression |
ISO |
Isoniazid affects the expression of MAP2 mRNA |
CTD |
PMID:22131109 |
|
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases phosphorylation multiple interactions |
ISO |
Isoniazid results in decreased phosphorylation of MAPK1 protein 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Quercetin inhibits the reaction [Isoniazid results in decreased phosphorylation of MAPK1 protein]]; Quercetin inhibits the reaction [Isoniazid results in decreased phosphorylation of MAPK1 protein] |
CTD |
PMID:31332904 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions decreases phosphorylation |
ISO |
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Quercetin inhibits the reaction [Isoniazid results in decreased phosphorylation of MAPK3 protein]]; Quercetin inhibits the reaction [Isoniazid results in decreased phosphorylation of MAPK3 protein] |
CTD |
PMID:31332904 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mgst1 |
microsomal glutathione S-transferase 1 |
increases expression |
ISO |
Isoniazid results in increased expression of MGST1 mRNA |
CTD |
PMID:33771660 |
|
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
|
|
G |
Mir106b |
microRNA 106b |
decreases expression |
EXP |
Isoniazide decreased expression of miR106b miRNA in the liver |
RGD |
PMID:29554950 |
RGD:15042854 |
NCBI chr12:17,043,344...17,043,425
Ensembl chr12:17,043,344...17,043,425
|
|
G |
Mir186 |
microRNA 186 |
multiple interactions |
ISO |
[Isoniazid co-treated with Rifampin] results in increased expression of MIR186 mRNA |
CTD |
PMID:32633153 |
|
NCBI chr 2:246,582,806...246,582,891
Ensembl chr 2:246,582,806...246,582,891
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions increases oxidation |
ISO |
[[MPO protein results in increased oxidation of Isoniazid] which results in increased chemical synthesis of Free Radicals] which results in increased chemical synthesis of isonicotinyl-NAD; [MPO protein results in increased oxidation of Isoniazid] which results in increased chemical synthesis of Free Radicals; [MPO protein results in increased oxidation of Isoniazid] which results in increased chemical synthesis of isonicotinyl-NAD |
CTD |
PMID:26867495 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mt-co3 |
mitochondrially encoded cytochrome c oxidase III |
increases expression |
EXP |
Isoniazid results in increased expression of COX3 mRNA |
CTD |
PMID:12883083 |
|
NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382
Ensembl chr MT:8,599...9,382
|
|
G |
Muc1 |
mucin 1, cell surface associated |
increases expression |
ISO |
Isoniazid results in increased expression of MUC1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
|
|
G |
Nat2 |
N-acetyltransferase 2 |
increases acetylation affects response to substance affects metabolic processing increases metabolic processing decreases acetylation multiple interactions decreases expression affects acetylation |
ISO EXP |
NAT2 protein polymorphism results in increased acetylation of Isoniazid; NAT2 protein results in increased acetylation of Isoniazid NAT2 gene polymorphism affects the susceptibility to Isoniazid; NAT2 gene SNP affects the susceptibility to Isoniazid NAT2 protein affects the metabolism of Isoniazid; NAT2 protein polymorphism affects the metabolism of Isoniazid NAT2 protein results in increased metabolism of Isoniazid NAT2 gene polymorphism results in decreased acetylation of Isoniazid [NAT2 gene polymorphism results in decreased acetylation of Isoniazid] which results in decreased abundance of acetylisoniazid; [NAT2 gene polymorphism results in decreased metabolism of Isoniazid] which results in increased abundance of hydrazine Isoniazid results in decreased expression of NAT2 mRNA [Zidovudine co-treated with Isoniazid] results in decreased expression of NAT2 mRNA; silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in decreased expression of NAT2 mRNA] NAT2 protein polymorphism affects the acetylation of Isoniazid |
CTD |
PMID:11379777 PMID:11915035 PMID:15546075 PMID:15565348 PMID:15618686 PMID:15627487 PMID:15908628 PMID:16531626 PMID:16847467 PMID:17509624 PMID:17973219 PMID:18544910 PMID:20485159 PMID:25794903 PMID:28619387 PMID:30358977 PMID:36040704 More...
|
|
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
|
|
G |
Ncr3lg1 |
natural killer cell cytotoxicity receptor 3 ligand 1 |
increases expression |
ISO |
Isoniazid results in increased expression of NCR3LG1 mRNA; Isoniazid results in increased expression of NCR3LG1 protein |
CTD |
PMID:32060585 |
|
NCBI chr 1:96,565,664...96,581,825
Ensembl chr 1:96,574,455...96,580,466
|
|
G |
Ndufa1 |
NADH:ubiquinone oxidoreductase subunit A1 |
affects expression |
ISO |
Isoniazid affects the expression of NDUFA1 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr X:116,424,223...116,427,875
Ensembl chr X:116,424,223...116,428,633
|
|
G |
Ndufa10 |
NADH:ubiquinone oxidoreductase subunit A10 |
affects expression |
ISO |
Isoniazid affects the expression of NDUFA10 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 9:93,007,034...93,041,825
Ensembl chr 9:93,007,042...93,042,560
|
|
G |
Ndufa12 |
NADH:ubiquinone oxidoreductase subunit A12 |
affects expression |
ISO |
Isoniazid affects the expression of NDUFA12 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 7:28,771,330...28,798,316
Ensembl chr 7:28,771,330...28,798,315
|
|
G |
Ndufa13 |
NADH:ubiquinone oxidoreductase subunit A13 |
affects expression |
ISO |
Isoniazid affects the expression of NDUFA13 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr16:19,526,633...19,533,567
Ensembl chr16:19,526,565...19,535,726 Ensembl chr 7:19,526,565...19,535,726
|
|
G |
Ndufa4 |
Ndufa4, mitochondrial complex associated |
affects expression |
ISO |
Isoniazid affects the expression of NDUFA4 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 4:40,002,216...40,009,384
Ensembl chr 4:40,002,216...40,023,920
|
|
G |
Ndufa5 |
NADH:ubiquinone oxidoreductase subunit A5 |
affects expression |
ISO |
Isoniazid affects the expression of NDUFA5 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 4:52,997,327...53,005,685
Ensembl chr 4:52,995,546...53,005,598 Ensembl chr 5:52,995,546...53,005,598
|
|
G |
Ndufa8 |
NADH:ubiquinone oxidoreductase subunit A8 |
affects expression |
ISO |
Isoniazid affects the expression of NDUFA8 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 3:19,386,062...19,402,090
Ensembl chr 3:19,386,065...19,402,071
|
|
G |
Ndufa9 |
NADH:ubiquinone oxidoreductase subunit A9 |
affects expression |
ISO |
Isoniazid affects the expression of NDUFA9 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 4:159,659,242...159,688,034
Ensembl chr 4:159,659,242...159,688,018
|
|
G |
Ndufab1 |
NADH:ubiquinone oxidoreductase subunit AB1 |
affects expression |
ISO |
Isoniazid affects the expression of NDUFAB1 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 1:176,644,696...176,658,131
Ensembl chr 1:176,644,703...176,658,099
|
|
G |
Ndufb10 |
NADH:ubiquinone oxidoreductase subunit B10 |
affects expression |
ISO |
Isoniazid affects the expression of NDUFB10 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr10:13,749,273...13,751,434
Ensembl chr10:13,749,275...13,751,442
|
|
G |
Ndufb2 |
NADH:ubiquinone oxidoreductase subunit B2 |
affects expression |
ISO |
Isoniazid affects the expression of NDUFB2 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 4:68,367,526...68,374,609
Ensembl chr15:46,536,062...46,536,851 Ensembl chr 4:46,536,062...46,536,851
|
|
G |
Ndufb3 |
NADH:ubiquinone oxidoreductase subunit B3 |
affects expression |
ISO |
Isoniazid affects the expression of NDUFB3 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 9:60,129,240...60,139,452
Ensembl chr 9:60,129,154...60,139,446
|
|
G |
Ndufb5 |
NADH:ubiquinone oxidoreductase subunit B5 |
affects expression |
ISO |
Isoniazid affects the expression of NDUFB5 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 2:115,519,248...115,533,589
Ensembl chr 2:115,519,154...115,533,589
|
|
G |
Ndufb6 |
NADH:ubiquinone oxidoreductase subunit B6 |
affects expression |
ISO |
Isoniazid affects the expression of NDUFB6 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 5:55,400,543...55,410,110
Ensembl chr 5:55,400,543...55,410,181
|
|
G |
Ndufb7 |
NADH:ubiquinone oxidoreductase subunit B7 |
affects expression |
ISO |
Isoniazid affects the expression of NDUFB7 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr19:24,568,241...24,572,579
Ensembl chr19:24,568,241...24,572,579
|
|
G |
Ndufs1 |
NADH:ubiquinone oxidoreductase core subunit S1 |
affects expression |
ISO |
Isoniazid affects the expression of NDUFS1 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 9:64,546,430...64,579,751
Ensembl chr 9:64,546,225...64,579,893
|
|
G |
Ndufs2 |
NADH:ubiquinone oxidoreductase core subunit S2 |
affects expression |
ISO |
Isoniazid affects the expression of NDUFS2 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr13:83,654,402...83,671,474
Ensembl chr13:83,654,406...83,671,420
|
|
G |
Ndufs3 |
NADH:ubiquinone oxidoreductase core subunit S3 |
affects expression |
ISO |
Isoniazid affects the expression of NDUFS3 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 3:76,876,646...76,883,824
Ensembl chr 3:76,876,646...76,883,824
|
|
G |
Ndufs4 |
NADH:ubiquinone oxidoreductase subunit S4 |
affects expression |
ISO |
Isoniazid affects the expression of NDUFS4 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 2:45,951,327...46,061,829
Ensembl chr 2:45,951,313...46,061,846
|
|
G |
Ndufs8 |
NADH:ubiquinone oxidoreductase core subunit S8 |
affects expression |
ISO |
Isoniazid affects the expression of NDUFS8 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 1:201,140,585...201,144,573
Ensembl chr 1:201,140,585...201,144,511
|
|
G |
Ndufv1 |
NADH:ubiquinone oxidoreductase core subunit V1 |
affects expression |
ISO |
Isoniazid affects the expression of NDUFV1 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 1:201,300,365...201,305,461
Ensembl chr 1:201,299,985...201,305,466
|
|
G |
Ndufv2 |
NADH:ubiquinone oxidoreductase core subunit V2 |
affects expression |
ISO |
Isoniazid affects the expression of NDUFV2 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 9:105,690,454...105,710,669
Ensembl chr 9:105,690,455...105,710,713
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases activity multiple interactions increases expression |
ISO EXP |
Isoniazid results in increased activity of NFE2L2 protein chrysin inhibits the reaction [Isoniazid results in increased expression of NFE2L2 mRNA] |
CTD |
PMID:30203046 PMID:33121995 PMID:33771660 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
increases expression multiple interactions |
EXP |
Isoniazid results in increased expression of NFKB1 mRNA chrysin inhibits the reaction [Isoniazid results in increased expression of NFKB1 mRNA] |
CTD |
PMID:33121995 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions decreases expression increases expression |
ISO EXP |
Isoniazid inhibits the reaction [2-tert-butylhydroquinone results in increased expression of NQO1 mRNA] Isoniazid results in decreased expression of NQO1 mRNA Isoniazid results in increased expression of NQO1 mRNA chrysin inhibits the reaction [Isoniazid results in increased expression of NQO1 mRNA] |
CTD |
PMID:24128855 PMID:28444390 PMID:33121995 PMID:33771660 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
decreases expression multiple interactions |
EXP ISO |
Isoniazid results in decreased expression of NR0B2 mRNA obeticholic acid inhibits the reaction [Isoniazid results in decreased expression of NR0B2 mRNA] [Isoniazid co-treated with Vitamin B 6] results in decreased expression of NR0B2 mRNA |
CTD |
PMID:32673658 |
|
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions decreases expression |
EXP ISO |
[Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] affects the expression of NR1H4; [Lipopolysaccharides co-treated with Isoniazid] results in decreased expression of NR1H4 mRNA; [Lipopolysaccharides co-treated with Isoniazid] results in decreased expression of NR1H4 protein; obeticholic acid inhibits the reaction [Isoniazid results in decreased expression of NR1H4 mRNA] isoniazide decreases expression of nr1h4 protein in rat liver [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] affects the expression of NR1H4; [Isoniazid co-treated with Vitamin B 6] results in decreased expression of NR1H4 mRNA |
CTD RGD |
PMID:25331106 PMID:32673658 PMID:35835356 PMID:30068870 |
RGD:15042870 |
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
increases activity |
ISO |
Isoniazid results in increased activity of NR1I3 protein |
CTD |
PMID:30203046 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nrf1 |
nuclear respiratory factor 1 |
multiple interactions decreases expression |
ISO |
acadesine inhibits the reaction [Isoniazid results in decreased expression of NRF1 protein] |
CTD |
PMID:28556920 |
|
NCBI chr 4:58,664,932...58,772,328
Ensembl chr 4:58,664,957...58,825,328
|
|
G |
Nupr1 |
nuclear protein 1, transcriptional regulator |
increases expression |
ISO |
Isoniazid results in increased expression of NUPR1 mRNA |
CTD |
PMID:17175557 |
|
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
|
|
G |
Ogdh |
oxoglutarate dehydrogenase |
affects expression |
ISO |
Isoniazid affects the expression of OGDH mRNA |
CTD |
PMID:24848797 |
|
NCBI chr14:81,150,021...81,217,479
Ensembl chr14:81,150,091...81,217,479
|
|
G |
Park7 |
Parkinsonism associated deglycase |
affects expression |
ISO |
Isoniazid affects the expression of PARK7 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 5:161,353,718...161,376,993
Ensembl chr 5:161,353,719...161,376,970
|
|
G |
Pid1 |
phosphotyrosine interaction domain containing 1 |
increases expression |
ISO |
Isoniazid results in increased expression of PID1 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 9:85,284,335...85,503,035
Ensembl chr 9:85,284,335...85,503,044
|
|
G |
Plod2 |
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
increases expression |
ISO |
Isoniazid results in increased expression of PLOD2 mRNA |
CTD |
PMID:15997088 |
|
NCBI chr 8:93,084,548...93,167,255
Ensembl chr 8:93,084,513...93,167,255
|
|
G |
Por |
cytochrome p450 oxidoreductase |
multiple interactions decreases expression |
EXP |
[Zidovudine co-treated with Isoniazid] results in decreased expression of POR mRNA; silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in decreased expression of POR mRNA] Isoniazid results in decreased expression of POR mRNA |
CTD |
PMID:28619387 |
|
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
increases activity multiple interactions |
ISO |
Isoniazid results in increased activity of PPARA protein [Isoniazid co-treated with Rifampin] results in decreased expression of PPARA protein |
CTD |
PMID:30203046 PMID:36347327 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
decreases expression multiple interactions |
ISO |
Isoniazid results in decreased expression of PPARG mRNA Isoniazid results in decreased expression of PPARG mRNA; Isoniazid results in decreased expression of PPARG protein [Isoniazid co-treated with Rifampin] results in decreased expression of PPARG protein |
CTD |
PMID:24128855 PMID:36347327 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
decreases expression multiple interactions |
ISO |
Isoniazid results in decreased expression of PPARGC1A protein acadesine inhibits the reaction [Isoniazid results in decreased expression of PPARGC1A protein] |
CTD |
PMID:28556920 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Psen1 |
presenilin 1 |
affects expression |
ISO |
Isoniazid affects the expression of PSEN1 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 6:103,323,052...103,375,088
Ensembl chr 6:103,323,120...103,371,650
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression |
ISO |
Isoniazid results in increased expression of PTGS2 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Sdha |
succinate dehydrogenase complex flavoprotein subunit A |
affects expression |
ISO |
Isoniazid affects the expression of SDHA mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 1:28,935,965...28,960,936
Ensembl chr 1:28,940,164...28,961,535
|
|
G |
Sdhb |
succinate dehydrogenase complex iron sulfur subunit B |
affects expression |
ISO |
Isoniazid affects the expression of SDHB mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 5:153,264,906...153,285,570
Ensembl chr 5:153,264,899...153,314,293
|
|
G |
Sdhd |
succinate dehydrogenase complex subunit D |
affects expression |
ISO |
Isoniazid affects the expression of SDHD mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 8:50,944,702...50,954,298
Ensembl chr 8:50,944,704...50,954,238
|
|
G |
Sfn |
stratifin |
decreases expression |
ISO |
Isoniazid results in decreased expression of SFN mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions decreases expression |
ISO |
acadesine inhibits the reaction [Isoniazid results in decreased expression of SIRT1 protein]; Quercetin inhibits the reaction [Isoniazid results in decreased expression of SIRT1 protein] |
CTD |
PMID:28556920 PMID:31332904 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slc10a1 |
solute carrier family 10 member 1 |
decreases expression multiple interactions |
EXP ISO |
Isoniazid results in decreased expression of SLC10A1 mRNA obeticholic acid promotes the reaction [Isoniazid results in decreased expression of SLC10A1 mRNA] [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in increased expression of SLC10A1 [Rifampin co-treated with Isoniazid] results in decreased expression of SLC10A1 protein Isoniazid results in decreased expression of SLC10A1 protein |
CTD |
PMID:25886055 PMID:32673658 PMID:35835356 |
|
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
|
|
G |
Slc11a1 |
solute carrier family 11 member 1 |
affects expression |
EXP |
Isoniazid affects the expression of SLC11A1 mRNA |
CTD |
PMID:20623750 |
|
NCBI chr 9:75,957,193...75,968,115
Ensembl chr 9:75,957,316...75,968,101
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
multiple interactions |
EXP |
[Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of SLC7A11 mRNA; [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of SLC7A11 protein; HIF1A protein affects the reaction [[Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of SLC7A11 protein] |
CTD |
PMID:36878459 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
decreases expression |
ISO |
Isoniazid results in decreased expression of SLC7A5 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
|
|
G |
Slco1c1 |
solute carrier organic anion transporter family, member 1c1 |
decreases expression |
EXP |
Isoniazid results in decreased expression of SLCO1B1 mRNA |
CTD |
PMID:32673658 |
|
NCBI chr 4:174,466,621...174,513,290
Ensembl chr 4:174,466,631...174,513,289
|
|
G |
Slpi |
secretory leukocyte peptidase inhibitor |
increases expression |
ISO |
Isoniazid results in increased expression of SLPI mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
|
|
G |
Sod1 |
superoxide dismutase 1 |
increases expression |
ISO |
Isoniazid results in increased expression of SOD1 mRNA |
CTD |
PMID:33771660 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions affects expression |
EXP ISO |
[SOD2 co-treated with CYP3A4] affects the susceptibility to Isoniazid Isoniazid affects the expression of SOD2 mRNA |
CTD |
PMID:19501153 PMID:24848797 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
affects expression decreases expression |
EXP ISO |
Isoniazid affects the expression of SPP1 mRNA Isoniazid results in decreased expression of SPP1 mRNA |
CTD |
PMID:20623750 PMID:30008028 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Srxn1 |
sulfiredoxin 1 |
increases expression |
ISO |
Isoniazid results in increased expression of SRXN1 mRNA |
CTD |
PMID:28444390 |
|
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
Surf1 |
SURF1, cytochrome c oxidase assembly factor |
affects expression |
ISO |
Isoniazid affects the expression of SURF1 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 3:10,241,793...10,244,686
Ensembl chr 3:10,241,837...10,263,315
|
|
G |
Tf |
transferrin |
increases expression |
EXP |
Isoniazid results in increased expression of TF mRNA |
CTD |
PMID:12883083 |
|
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
|
|
G |
Tnf |
tumor necrosis factor |
increases expression increases secretion multiple interactions |
EXP ISO |
Isoniazid results in increased expression of TNF protein Isoniazid results in increased secretion of TNF protein [Isoniazid co-treated with Zidovudine] results in increased expression of TNF protein; chrysin inhibits the reaction [Isoniazid results in increased expression of TNF protein]; Isoniazid promotes the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Silybin inhibits the reaction [[Isoniazid co-treated with Zidovudine] results in increased expression of TNF protein] |
CTD |
PMID:25331106 PMID:28444390 PMID:28619387 PMID:33121995 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tpo |
thyroid peroxidase |
decreases activity |
EXP |
Isoniazid results in decreased activity of TPO protein |
CTD |
PMID:26884060 |
|
NCBI chr 6:46,698,402...46,768,199
Ensembl chr 6:46,698,414...46,768,199
|
|
G |
Trak1 |
trafficking kinesin protein 1 |
affects expression |
ISO |
Isoniazid affects the expression of TRAK1 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 8:120,984,445...121,139,357
Ensembl chr 8:120,984,431...121,139,367
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
increases expression |
ISO |
Isoniazid results in increased expression of TRIB3 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Txn2 |
thioredoxin 2 |
affects expression |
ISO |
Isoniazid affects the expression of TXN2 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
increases expression |
ISO |
Isoniazid results in increased expression of TXNRD1 mRNA |
CTD |
PMID:28444390 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Txnrd2 |
thioredoxin reductase 2 |
affects expression |
ISO |
Isoniazid affects the expression of TXNRD2 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156
|
|
G |
Uqcrb |
ubiquinol-cytochrome c reductase binding protein |
affects expression |
ISO |
Isoniazid affects the expression of UQCRB mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 7:63,814,784...63,820,150
Ensembl chr 7:63,814,797...63,820,150
|
|
G |
Uqcrc2 |
ubiquinol cytochrome c reductase core protein 2 |
affects expression |
ISO |
Isoniazid affects the expression of UQCRC2 mRNA |
CTD |
PMID:24848797 |
|
NCBI chr 1:175,167,933...175,198,499
Ensembl chr 1:175,167,894...175,199,453
|
|
|
G |
Mpo |
myeloperoxidase |
increases oxidation |
ISO |
MPO protein results in increased oxidation of (N)1-acetylisoniazid |
CTD |
PMID:26867495 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|